Back to Search
Start Over
Gefitinib versus cetuximab in lung cancer: round one.
- Source :
-
Journal of the National Cancer Institute [J Natl Cancer Inst] 2005 Aug 17; Vol. 97 (16), pp. 1168-9. - Publication Year :
- 2005
- Subjects :
- Antibodies, Monoclonal pharmacology
Antibodies, Monoclonal, Humanized
Antineoplastic Agents pharmacology
Carcinoma, Non-Small-Cell Lung metabolism
Cetuximab
Drug Synergism
ErbB Receptors antagonists & inhibitors
ErbB Receptors genetics
Gefitinib
Humans
Lung Neoplasms metabolism
Mutation
Protein Kinase Inhibitors therapeutic use
Protein-Tyrosine Kinases antagonists & inhibitors
Quinazolines pharmacology
Receptor, ErbB-2 drug effects
Antibodies, Monoclonal therapeutic use
Antineoplastic Agents therapeutic use
Carcinoma, Non-Small-Cell Lung drug therapy
Lung Neoplasms drug therapy
Quinazolines therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1460-2105
- Volume :
- 97
- Issue :
- 16
- Database :
- MEDLINE
- Journal :
- Journal of the National Cancer Institute
- Publication Type :
- Report
- Accession number :
- 16106015
- Full Text :
- https://doi.org/10.1093/jnci/dji247